Published in Vaccine Weekly, December 22nd, 2010
About IDRI - Translating science into global health solutions
IDRI is a Seattle-based not-for-profit organization committed to applying innovative science to the research and development of products to prevent, detect, and treat infectious diseases of poverty. By integrating capabilities -- including preclinical vaccinology, manufacturing, and clinical trials -- IDRI strives to create an efficient pathway bringing scientific innovation from the lab to the people who need it most.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.